Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RBM14-RBM4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CCHCR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CTSO - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ORC1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
COX5B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HAUS5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
COX6B1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FTL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BOLA2B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MRPL48 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IKBKE - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PPP3CC - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TCP10 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
KIR2DS3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors
PSME1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ADTRP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KPNA6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CDIPT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARL14 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EIF4EBP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on